Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment

ConclusionsWomen withBRCA1/2 mutations indicated strong preferences for breast cancer risk reduction and maintaining fertility. The expressed desire to have a safe chemoprevention drug available to them was not met by current chemoprevention options.

Source: Breast Cancer Research and Treatment - August 3, 2017 Category: Cancer & Oncology Source Type: research